TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36199075

Group type: EXPERIMENTAL
Intervention: Modified Flinders Program plus usual care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 33722420

Group type: EXPERIMENTAL
Intervention: Olaparib (PARP inhibitor)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control arm (not specified)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Radiographic progression-free survival
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mutations in homologous recombination repair genes other than BRCA1, BRCA2, and ATM
Number of subjects: 0
Study: 33372114

Group type: EXPERIMENTAL
Intervention: 20 module classroom‐based intervention program
Number of subjects: 434

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 434
Study: 36310622

Group type: EXPERIMENTAL
Intervention: Tai Chi training for 12 weeks followed by 12 weeks of self-practice
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waiting list control group maintaining usual lifestyle for 24 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tai Chi training for 12 weeks
Number of subjects: 0
Study: 32265117

Group type: EXPERIMENTAL
Intervention: High completion group (4-5 cycles of irinotecan)
Number of subjects: 371

Group type: COMPARATOR
Intervention: Low completion group (1-3 cycles of irinotecan)
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: CinClare group (high completion)
Number of subjects: 371

Group type: COMPARATOR
Intervention: CinClare group (low completion)
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: High completion rates across risk groups
Number of subjects: 371
Study: 33753430

Group type: EXPERIMENTAL
Intervention: Brief intervention about work-related stress, including training for GPs, screening of patients' work-related stress, feedback to patients on screening results and discussion of measures at GP consultation
Number of subjects: 271

Group type: COMPARATOR
Intervention: Treatment as usual (Control)
Number of subjects: 271

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 271
Study: 35721170

Group type: EXPERIMENTAL
Intervention: XueBiJing treatment (100 ml, q12 h for 5–7 days)
Number of subjects: 425

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 425

Group type: EXPERIMENTAL
Intervention: XueBiJing treatment and Placebo treatment
Number of subjects: 425
Study: 32534972

Group type: EXPERIMENTAL
Intervention: VectorFlow catheter
Number of subjects: 100

Group type: COMPARATOR
Intervention: Palindrome catheter
Number of subjects: 100
Study: 34534353

Group type: EXPERIMENTAL
Intervention: Whole-food/well-formulated ketogenic diet (WFKD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Minimally processed whole-food diet (WFD)
Number of subjects: 0
Study: 34035871

Group type: EXPERIMENTAL
Intervention: Low-Intensity Pulsed Ultrasound (LIPUS) applied at 1.1 MHz frequency and 30 mW/cm2 intensity output for 20 minutes extraorally, reapplied after 3 weeks for 2 more visits.
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo (no LIPUS treatment).
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Low-Intensity Pulsed Ultrasound (LIPUS) treatment.
Number of subjects: 22
Study: 32059021

Group type: EXPERIMENTAL
Intervention: Standardized strategy
Number of subjects: 903

Group type: COMPARATOR
Intervention: Open strategy
Number of subjects: 903
Study: 36252718

Group type: EXPERIMENTAL
Intervention: Dexamethasone (24 mg intravenously, perioperatively)
Number of subjects: 290

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 290

Group type: COMPARATOR
Intervention: Dexamethasone and Placebo
Number of subjects: 290
Study: 34472755

Group type: EXPERIMENTAL
Intervention: Tiaoshen needling (acupuncture or electroacupuncture at Baihui (GV20), Shenting (GV24), Yintang (GV29), bilateral Shenmen (HT7), and Sanyinjiao (SP6))
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (acupuncture or electroacupuncture at bilateral Shousanli (LI10), Futu (ST32), and Feiyang (BL58))
Number of subjects: 60
Study: 36175281

Group type: EXPERIMENTAL
Intervention: Target Saturation Biopsy (TS) with nine cores
Number of subjects: 170

Group type: COMPARATOR
Intervention: Conventional Targeted Biopsy (TB) with four cores
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Target Saturation Biopsy (TS)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Conventional Targeted Biopsy (TB)
Number of subjects: 170
Study: 32690432

Group type: EXPERIMENTAL
Intervention: Genetically predicted serum iron (1-SD increase)
Number of subjects: 48972
Study: 32690147

Group type: EXPERIMENTAL
Intervention: Sesame-canola oil
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Canola oil
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Canola oil and sesame-canola oils
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Sesame oil
Number of subjects: 168
Study: 33902652

Group type: EXPERIMENTAL
Intervention: Dietitian adherence to a written nutrition plan
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Dietitian adherence to behaviour change counselling
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Competence in delivering behaviour change counselling
Number of subjects: 194
Study: 33455457

Group type: EXPERIMENTAL
Intervention: 25-minutes high-intensity intervals (10, one-minute intervals at 85-90% heart-rate reserve)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 45-minutes of moderate-intensity exercise (at 50-60% heart-rate reserve)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control condition (30-minutes quiet rest)
Number of subjects: 9
Study: 32618207

Group type: EXPERIMENTAL
Intervention: Multimodal therapy (MT)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Combined therapy (CT)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Standard aerobic training (AT)
Number of subjects: 105
Study: 35319652

Group type: EXPERIMENTAL
Intervention: Group 2020 (COVID-19 pandemic)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Group 2019 (pre-COVID-19 pandemic)
Number of subjects: 2
Study: 33245746

Group type: EXPERIMENTAL
Intervention: Tofacitinib 10 mg BID
Number of subjects: 1220

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1220

Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 mg BID
Number of subjects: 1220

Group type: EXPERIMENTAL
Intervention: Overall Cohort (Tofacitinib 10 mg BID predominantly)
Number of subjects: 1220
Study: 36136830

Group type: EXPERIMENTAL
Intervention: Parent-adolescent treatment group
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Parent only treatment group
Number of subjects: 225

Group type: COMPARATOR
Intervention: Self-study control group
Number of subjects: 225

Group type: COMPARATOR
Intervention: No treatment control group
Number of subjects: 225
Study: 34831759

Group type: EXPERIMENTAL
Intervention: Developmental Network (DN) coaching
Number of subjects: 220

Group type: COMPARATOR
Intervention: NCR algorithm
Number of subjects: 220
Study: 35832268

Group type: EXPERIMENTAL
Intervention: Opaganib
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 32390072

Group type: EXPERIMENTAL
Intervention: Ospemifene plus standard of care (SoC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ospemifene
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care (SoC) alone
Number of subjects: 0
Study: 32520346

Group type: EXPERIMENTAL
Intervention: Low-fat dairy (LF) group incorporated ≥3 servings/d of LF dairy
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: High-fat dairy (HF) group incorporated ≥3 servings/d of HF dairy
Number of subjects: 111

Group type: COMPARATOR
Intervention: Control group maintained baseline dairy intake
Number of subjects: 111
Study: 35389487

Group type: EXPERIMENTAL
Intervention: n-3-PUFA ethyl esters (3.9 g/d)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo (corn oil)
Number of subjects: 54
Study: 33434676

Group type: EXPERIMENTAL
Intervention: Ceftolozane/tazobactam 3 g q8h
Number of subjects: 117

Group type: COMPARATOR
Intervention: Meropenem 1 g q8h
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Ceftolozane/tazobactam
Number of subjects: 117

Group type: COMPARATOR
Intervention: Meropenem
Number of subjects: 117
Study: 32739862

Group type: EXPERIMENTAL
Intervention: SCST + TAU
Number of subjects: 47

Group type: COMPARATOR
Intervention: TAU only
Number of subjects: 47
Study: 35587064

Group type: EXPERIMENTAL
Intervention: McKenzie exercises
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Deep neck flexor (DNF) combined with scapulothoracic exercises
Number of subjects: 55

Group type: COMPARATOR
Intervention: Traditional physical therapy (control)
Number of subjects: 55
Study: 34243100

Group type: EXPERIMENTAL
Intervention: Connect for Kinship Parents (Connect-KP)
Number of subjects: 26

Group type: COMPARATOR
Intervention: care-as-usual (CAU)
Number of subjects: 26
Study: 35178664

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 33754453

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT; n=77)
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Moderate Continuous Training (MCT; n=63)
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Recommendation of Regular Exercise (RRE; n=73)
Number of subjects: 213
Study: 32656865

Group type: EXPERIMENTAL
Intervention: CART model
Number of subjects: 512

Group type: EXPERIMENTAL
Intervention: Nomogram model
Number of subjects: 512
Study: 36214157

Group type: EXPERIMENTAL
Intervention: Somofilcon-A
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Omafilcon-A
Number of subjects: 28

Group type: COMPARATOR
Intervention: Somofilcon-A and Omafilcon-A
Number of subjects: 28
Study: 33932520

Group type: EXPERIMENTAL
Intervention: Caffeine supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 32040038

Group type: EXPERIMENTAL
Intervention: Bundled rapid HIV and HCV tests with immediate results on-site
Number of subjects: 162

Group type: COMPARATOR
Intervention: Standard of care (referrals to onsite or off-site laboratory-based HIV and HCV testing with delayed results)
Number of subjects: 162
Study: 34332028

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 2400 mg/day and working memory training for 25 days
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo with working memory training for 25 days
Number of subjects: 38
Study: 32368942

Group type: EXPERIMENTAL
Intervention: Elastic bandage treatment
Number of subjects: 65

Group type: COMPARATOR
Intervention: Cast immobilization
Number of subjects: 65
Study: 36315948

Group type: EXPERIMENTAL
Intervention: Intravenous tenecteplase
Number of subjects: 0

Group type: COMPARATOR
Intervention: Alteplase
Number of subjects: 0
Study: 33135094

Group type: COMPARATOR
Intervention: Case detection strategies using the COPD Diagnostic Questionnaire (CDQ) at 3-year intervals
Number of subjects: 0

Group type: COMPARATOR
Intervention: All 16 case detection strategies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Treatment for smoking cessation and guideline-based inhaler pharmacotherapy for newly diagnosed patients
Number of subjects: 0
Study: 33946648

Group type: EXPERIMENTAL
Intervention: High frequency dTMS
Number of subjects: 22

Group type: COMPARATOR
Intervention: Low frequency dTMS
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 22
Study: 35075598

Group type: EXPERIMENTAL
Intervention: MTA
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: LLLT-MTA (Low Level Laser Therapy with MTA)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: DL-MTA (High Power Diode Laser with MTA)
Number of subjects: 63
Study: 35416730

Group type: EXPERIMENTAL
Intervention: E-contact intervention
Number of subjects: 170

Group type: COMPARATOR
Intervention: Intrgroup interaction (control)
Number of subjects: 170
Study: 34067389

Group type: EXPERIMENTAL
Intervention: Nature video viewing during exercise period
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Nature video viewing during recovery period
Number of subjects: 18

Group type: COMPARATOR
Intervention: Black screen during exercise period
Number of subjects: 18

Group type: COMPARATOR
Intervention: Black screen during recovery period
Number of subjects: 18
Study: 35804354

Group type: EXPERIMENTAL
Intervention: Veteran Sponsorship Initiative (VSI)
Number of subjects: 630
Study: 32703779

Group type: EXPERIMENTAL
Intervention: Pirfenidone plus inhaled N-acetylcysteine 352.4 mg twice daily
Number of subjects: 81

Group type: COMPARATOR
Intervention: Pirfenidone alone
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Pirfenidone plus inhaled N-acetylcysteine
Number of subjects: 81
Study: 32221490

Group type: EXPERIMENTAL
Intervention: ART with high viscosity GIC
Number of subjects: 154

Group type: COMPARATOR
Intervention: Composite restoration
Number of subjects: 154
Study: 36343758

Group type: EXPERIMENTAL
Intervention: Tiotropium Respimat® 5 μg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34601232

Group type: EXPERIMENTAL
Intervention: Moderate cardiovascular exercise (150 min/week, 30 min/day for 5 days a week for 6 months)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Relaxation exercises (20 min at least five times per week for 6 months)
Number of subjects: 28
Study: 32782200

Group type: EXPERIMENTAL
Intervention: Adjuvant chemoradiotherapy (CRT)
Number of subjects: 217

Group type: COMPARATOR
Intervention: Adjuvant chemotherapy alone (CTx)
Number of subjects: 217

Group type: COMPARATOR
Intervention: No adjuvant therapy (noTx)
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Adjuvant chemoradiotherapy (CRT) with radiation dose ≥54 Gy
Number of subjects: 217
Study: 35656822

Group type: EXPERIMENTAL
Intervention: Vericiguat
Number of subjects: 5050

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5050
Study: 34818479

Group type: EXPERIMENTAL
Intervention: Preimplantation genetic testing for aneuploidy (PGT‐A)
Number of subjects: 1212

Group type: COMPARATOR
Intervention: Conventional in vitro fertilization (IVF)
Number of subjects: 1212

Group type: EXPERIMENTAL
Intervention: PGT‐A
Number of subjects: 1212

Group type: COMPARATOR
Intervention: Conventional IVF
Number of subjects: 1212

Group type: EXPERIMENTAL
Intervention: PGT‐A and Conventional IVF
Number of subjects: 1212
Study: 36108766

Group type: EXPERIMENTAL
Intervention: Multiple falls (32 participants)
Number of subjects: 428

Group type: COMPARATOR
Intervention: No falls (299 participants)
Number of subjects: 428

Group type: EXPERIMENTAL
Intervention: Single fall
Number of subjects: 428
Study: 32910450

Group type: EXPERIMENTAL
Intervention: sos training (care as usual plus sos training)
Number of subjects: 250

Group type: COMPARATOR
Intervention: care as usual (control group)
Number of subjects: 250
Study: 36151016

Group type: EXPERIMENTAL
Intervention: L-PRF
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control (no L-PRF)
Number of subjects: 15
Study: 32926117

Group type: EXPERIMENTAL
Intervention: Transcranial Low-Level Light Therapy (LLLT)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Sham Therapy
Number of subjects: 68
Study: 35544437

Group type: EXPERIMENTAL
Intervention: Altruism-eliciting short animated video intervention
Number of subjects: 1373

Group type: COMPARATOR
Intervention: Text-based intervention focused on non-vaccine-related COVID-19 preventive health measures
Number of subjects: 1373
Study: 32348081

Group type: EXPERIMENTAL
Intervention: 30% hydrogen peroxide
Number of subjects: 85

Group type: COMPARATOR
Intervention: 50% trichloroacetic acid
Number of subjects: 85
Study: 32163834

Group type: EXPERIMENTAL
Intervention: Mindfulness meditation
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Device-guided slow breathing
Number of subjects: 73

Group type: COMPARATOR
Intervention: Waiting-list control
Number of subjects: 73
Study: 34346134

Group type: EXPERIMENTAL
Intervention: Mobilization protocol applied on the 0th postoperative day
Number of subjects: 42
Study: 34108181

Group type: EXPERIMENTAL
Intervention: Atezolizumab + Radium-223
Number of subjects: 45
Study: 32084142

Group type: COMPARATOR
Intervention: IFN Nebulization 2 (2 μg/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: IFN Nebulization 1 (1 μg/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study: 36471382

Group type: EXPERIMENTAL
Intervention: Teleconsultations by specialists for neurology and palliative medicine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group with interventions after a 12-month delay
Number of subjects: 0
Study: 33879349

Group type: EXPERIMENTAL
Intervention: Plasma MMP‐2
Number of subjects: 387

Group type: EXPERIMENTAL
Intervention: Plasma MMP‐9
Number of subjects: 387
Study: 35557247

Group type: EXPERIMENTAL
Intervention: Capsaicin
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 32819321

Group type: EXPERIMENTAL
Intervention: dorsomedial prefrontal intermittent theta burst stimulation (iTBS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: sham treatment
Number of subjects: 0
Study: 33957713

Group type: EXPERIMENTAL
Intervention: Steam bath intervention (10-15 min session once a week for 12 weeks)
Number of subjects: 40
Study: 34462030

Group type: EXPERIMENTAL
Intervention: Unipolar mania
Number of subjects: 80

Group type: COMPARATOR
Intervention: Bipolar disorder
Number of subjects: 80
Study: 33769573

Group type: EXPERIMENTAL
Intervention: FAR angle measurement in CSP
Number of subjects: 15

Group type: COMPARATOR
Intervention: FAR angle measurement in normal pregnancies
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: ROC curve analysis for FAR angle
Number of subjects: 15
Study: 33574009

Group type: EXPERIMENTAL
Intervention: 2 mL LR-PRP injection (single dose)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 2 mL LR-PRP injection (double dose)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Both groups (single and double dose)
Number of subjects: 60
Study: 36181292

Group type: EXPERIMENTAL
Intervention: 308 nm excimer laser
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 0.1% tacrolimus
Number of subjects: 21

Group type: COMPARATOR
Intervention: Both treatments
Number of subjects: 21
Study: 34615756

Group type: EXPERIMENTAL
Intervention: Secondary decompressive craniectomy (DC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Primary decompressive craniectomy (DC)
Number of subjects: 0
Study: 32799871

Group type: EXPERIMENTAL
Intervention: Videos with non-native English accent (NNEA)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Videos without non-native English accent
Number of subjects: 42
Study: 35339102

Group type: EXPERIMENTAL
Intervention: 700/35 mg foslevodopa/foscarbidopa subcutaneous infusion over 24 h
Number of subjects: 25

Group type: COMPARATOR
Intervention: 350/87.5 mg LD/CD administered over 16 h followed by two 100/25 mg LD/CD oral doses
Number of subjects: 25
Study: 33492637

Group type: EXPERIMENTAL
Intervention: Convalescent plasma (CP) therapy
Number of subjects: 0
Study: 32558416

Group type: EXPERIMENTAL
Intervention: UDCA 5 mg/kg/dose every 12 hours orally with phototherapy
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: UDCA 7.5 mg/kg/dose every 12 hours orally with phototherapy
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo with phototherapy
Number of subjects: 120
Study: 32517477

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (weekly for five consecutive weeks)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (pre-treatment effect)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (late intervention with 6-week delay)
Number of subjects: 70
Study: 33271482

Group type: EXPERIMENTAL
Intervention: Anodal tDCS
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 20
Study: 33971993

Group type: EXPERIMENTAL
Intervention: Pecan nuts group (30 g/d of pecans + healthy diet)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Extra-virgin olive oil group (30 ml/d of extra-virgin olive oil + healthy diet)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Control group (healthy diet)
Number of subjects: 204
Study: 32436318

Group type: EXPERIMENTAL
Intervention: Sulforaphane (SFN)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study: 32833851

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided intermediate cervical plexus block (Group-1) with 10ml of 0.5% bupivacaine
Number of subjects: 50

Group type: COMPARATOR
Intervention: Ultrasound-guided superficial cervical plexus block (Group-2) with 10ml of 0.5% bupivacaine
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided intermediate cervical plexus block (Group-1)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Ultrasound-guided superficial cervical plexus block (Group-2)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study: 36087699

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral intervention (SEKT)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Emotion-focused intervention (FEST)
Number of subjects: 59
Study: 33206059

Group type: EXPERIMENTAL
Intervention: Recommended care with telerehabilitation (including a weekly group teleconference session)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Recommended care (internet-delivered evidence-based exercise and education)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Advice only
Number of subjects: 36
Study: 36129233

Group type: EXPERIMENTAL
Intervention: RHA-M (hyaluronic acid fillers with mepivacaine)
Number of subjects: 30

Group type: COMPARATOR
Intervention: RHA (hyaluronic acid fillers with lidocaine)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: RHA-M
Number of subjects: 30

Group type: COMPARATOR
Intervention: RHA
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: RHA-M and RHA
Number of subjects: 30
Study: 32488263

Group type: EXPERIMENTAL
Intervention: FDC 25/25
Number of subjects: 829

Group type: EXPERIMENTAL
Intervention: FDC 50/50
Number of subjects: 829

Group type: COMPARATOR
Intervention: D50
Number of subjects: 829

Group type: COMPARATOR
Intervention: T50
Number of subjects: 829
Study: 32980384

Group type: EXPERIMENTAL
Intervention: Intensity-modulated radiation therapy (IMRT)
Number of subjects: 693

Group type: COMPARATOR
Intervention: 3-dimensional conformal radiotherapy (3D-CRT)
Number of subjects: 693
Study: 33261578

Group type: EXPERIMENTAL
Intervention: Animal-Assisted Therapy (AAT) with a bird for eight weeks
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Animal-Assisted Therapy (AAT)
Number of subjects: 70
Study: 35613759

Group type: EXPERIMENTAL
Intervention: Balanced Binocular Viewing (BBV)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Standard occlusion/atropine blurring
Number of subjects: 44